Intestinal Permeability In Patients With Crohn’s Disease And Their Healthy Relatives

This 1989 study investigated whether "leaky gut" - increased intestinal permeability - might run in families of people with Crohn's disease, a chronic inflammatory bowel condition. The researchers tested how well the intestinal lining acts as a barrier by having participants drink solutions containing different test molecules (lactulose, rhamnose, and mannitol) and measuring how much passed through into their bloodstream.

The study included 25 patients with active Crohn's disease, 41 of their healthy relatives, and 29 people with no family history of inflammatory bowel disease as controls. As expected, people with Crohn's disease showed significantly increased intestinal permeability compared to both groups. However, the healthy relatives showed normal gut barrier function - similar to the unrelated healthy controls - when tested with these particular molecules.

Interestingly, previous research had found that healthy relatives of Crohn's patients did show increased permeability when tested with a different molecule called polyethylene glycol 400. This suggests that different test substances may detect different types of gut barrier problems, and that there might be both genetic factors (affecting relatives) and inflammation-related factors (in active disease) that influence intestinal permeability.

For metabolic health, this research highlights the complex relationship between gut barrier function, inflammation, and genetic predisposition. In clinical practice, understanding intestinal permeability can help practitioners assess gut health and develop targeted interventions to support the intestinal barrier, which plays a crucial role in immune function, nutrient absorption, and overall metabolic wellness.